← FDA DRUG APPROVALS

FDA ANDA · ANDA206206

ROCURONIUM BROMIDE

Sponsor: EUGIA PHARMA

APPLICATION
ANDA206206
TYPE
ANDA
ORIGINAL APPROVAL
2017-04-12
LATEST ACTION
2019-05-03
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

ROCURONIUM BROMIDEPrescription
ROCURONIUM BROMIDE 50MG/5ML (10MG/ML) · INJECTABLE · INJECTION
ROCURONIUM BROMIDEPrescription
ROCURONIUM BROMIDE 100MG/10ML (10MG/ML) · INJECTABLE · INJECTION

Approval history

2019-05-03Labeling · Supplement 3 · standardAP
2018-07-26Labeling · Supplement 2 · standardAP
2017-04-12UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →